GLP-1 receptor agonist 9

CAS No. 2401892-71-3

GLP-1 receptor agonist 9( 1H-Benzimidazole-6-carboxylic acid )

Catalog No. M28775 CAS No. 2401892-71-3

1H-Benzimidazole-6-carboxylic acid is a GLP-1 receptor agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 302 Get Quote
10MG 447 Get Quote
25MG 714 Get Quote
50MG 1017 Get Quote
100MG 1368 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GLP-1 receptor agonist 9
  • Note
    Research use only, not for human use.
  • Brief Description
    1H-Benzimidazole-6-carboxylic acid is a GLP-1 receptor agonist.
  • Description
    1H-Benzimidazole-6-carboxylic acid is a GLP-1 receptor agonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    1H-Benzimidazole-6-carboxylic acid
  • Pathway
    GPCR/G Protein
  • Target
    Glucagon Receptor
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2401892-71-3
  • Formula Weight
    592.06
  • Molecular Formula
    C32H31ClFN3O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[C@@]1(c(ccc(Cl)c2)c2F)Oc(c(C2CCN(Cc3nc(ccc(C(O)=O)c4)c4n3C[C@H]3OCC3)CC2)ccc2)c2O1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Current Patent Assignee: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY; OCT - WO2004/37804, 2004, A1
molnova catalog
related products
  • MK-0893

    A potent, selective, reversible and competitive antagonist of glucagon receptor with high binding affinity (IC(=50=6.6 nM) and functional cAMP activity (IC50=15.7 nM).

  • HAEGTFTSDVS

    HAEGTFTSDVS is the first N-terminal 1-11 residues of GLP-1 peptide.

  • GLP-1R modulator C5

    GLP-1R modulator C5 is a small molecule GLP-1R orthosteric modulator that enhances GLP-1 binding to GLP-1R via transmembrane sites and can be used in the study of type II diabetes.